MIF and neoplasm: As shown in other studies, the MIF-CD74 pair can suppress the T cell mediated antitumor effect by directly inhibiting T cell activation, or promoting the recruitment of tumor-associated macrophages (TAMs), thus accelerate tumor progression (Balogh et al., 2018; Klemke et al., 2021).